Invention Grant
- Patent Title: Artificial introns
-
Application No.: US15222030Application Date: 2016-07-28
-
Publication No.: US09708636B2Publication Date: 2017-07-18
- Inventor: Barbara Enenkel
- Applicant: Boehringer Ingelheim International GmbH
- Applicant Address: DE Ingelheim am Rhein
- Assignee: Boehringer Ingelheim International GmbH
- Current Assignee: Boehringer Ingelheim International GmbH
- Current Assignee Address: DE Ingelheim am Rhein
- Agent Paula K. Wittmayer; Atabak R. Royaee
- Priority: EP12199814 20121231
- Main IPC: C12N15/13
- IPC: C12N15/13 ; C12N15/113 ; C12P21/00 ; C07K16/00 ; C12N15/67 ; C12N15/85 ; C07H21/04 ; C12P21/02 ; C12N5/10
Abstract:
The invention concerns the field of recombinant gene engineering. It concerns novel artificial introns and compositions comprising such introns as well as a method to improve expression of polypeptides from nucleic acids such as cloned genes, especially genes encoding antibodies and antibody derived fragments, and the production of various polypeptides in eukaryotic host cells using said novel artificial intron sequences.
Public/Granted literature
- US20160348143A1 ARTIFICIAL INTRONS Public/Granted day:2016-12-01
Information query
IPC分类:
